Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,260.02 +225.73 (+0.37%) CMC Crypto 200
1,266.00 -92.01 (-6.78%)
ETON May 2024 7.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:14PM EDT. Market open.
| Previous close | 0.0500 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.3000 |
| Strike | 7.50 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Simply Wall St.Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
Eton Pharmaceuticals ( NASDAQ:ETON ) First Quarter 2024 Results Key Financial Results Revenue: US$7.97m (up 50% from 1Q...
- Thomson Reuters StreetEvents
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
GlobeNewswireEton Pharmaceuticals Reports First Quarter 2024 Financial Results
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400• Management to hold conference call today at 4:30pm ET DEER PARK, Ill., May 09, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commerciali
© 2024 Yahoo. All rights reserved.